Geusens PP - Search Results

1

Measures of bioavailable serum testosterone and estradiol and their relationships with muscle mass, muscle strength and bone mineral density in postmenopausal women: a cross-sectional study.

van Geel TA, Geusens PP, Winkens B, Sels JP, Dinant GJ. van Geel TA, et al. Among authors: geusens pp. Eur J Endocrinol. 2009 Apr;160(4):681-7. doi: 10.1530/EJE-08-0702. Epub 2009 Jan 27. Eur J Endocrinol. 2009. PMID: 19174532

2

Total body mineral mass measured with dual photon absorptiometry in healthy children.

Proesmans W, Goos G, Emma F, Geusens P, Nijs J, Dequeker J. Proesmans W, et al. Eur J Pediatr. 1994 Nov;153(11):807-12. doi: 10.1007/BF01972888. Eur J Pediatr. 1994. PMID: 7843194

3

Effect of 1alpha-vitamin D3 and estrogen therapy on cortical bone mechanical properties in the ovariectomized rat model.

Aerssens J, van Audekercke R, Talalaj M, Geusens P, Bramm E, Dequeker J. Aerssens J, et al. Endocrinology. 1996 Apr;137(4):1358-64. doi: 10.1210/endo.137.4.8625911. Endocrinology. 1996. PMID: 8625911

4

Factors affecting bone loss in female endurance athletes: a two-year follow-up study.

Braam LA, Knapen MH, Geusens P, Brouns F, Vermeer C. Braam LA, et al. Am J Sports Med. 2003 Nov-Dec;31(6):889-95. doi: 10.1177/03635465030310062601. Am J Sports Med. 2003. PMID: 14623654 Clinical Trial.

5

Hip bone mineral density, bone turnover and risk of fracture in patients on long-term suppressive L-thyroxine therapy for differentiated thyroid carcinoma.

Heijckmann AC, Huijberts MS, Geusens P, de Vries J, Menheere PP, Wolffenbuttel BH. Heijckmann AC, et al. Among authors: geusens p. Eur J Endocrinol. 2005 Jul;153(1):23-9. doi: 10.1530/eje.1.01933. Eur J Endocrinol. 2005. PMID: 15994742

6

Timing and risk factors for clinical fractures among postmenopausal women: a 5-year prospective study.

van Geel AC, Geusens PP, Nagtzaam IF, Schreurs CM, van der Voort DJ, Rinkens PE, Kester AD, Dinant GJ. van Geel AC, et al. Among authors: geusens pp. BMC Med. 2006 Oct 9;4:24. doi: 10.1186/1741-7015-4-24. BMC Med. 2006. PMID: 17029622 Free PMC article.

7

Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis.

Jacobs JW, de Nijs RN, Lems WF, Geusens PP, Laan RF, Huisman AM, Algra A, Buskens E, Hofbauer LC, Oostveen AC, Bruyn GA, Dijkmans BA, Bijlsma JW. Jacobs JW, et al. Among authors: geusens pp. J Rheumatol. 2007 May;34(5):1051-7. Epub 2007 Apr 1. J Rheumatol. 2007. PMID: 17407214 Clinical Trial.

8

Risk of falling in patients with a recent fracture.

van Helden S, Wyers CE, Dagnelie PC, van Dongen MC, Willems G, Brink PR, Geusens PP. van Helden S, et al. Among authors: geusens pp. BMC Musculoskelet Disord. 2007 Jun 28;8:55. doi: 10.1186/1471-2474-8-55. BMC Musculoskelet Disord. 2007. PMID: 17598891 Free PMC article.

9

Risk factors for clinical fractures among postmenopausal women: a 10-year prospective study.

van Geel TA, Geusens PP, Nagtzaam IF, van der Voort DJ, Schreurs CM, Rinkens PE, Dinant GJ. van Geel TA, et al. Among authors: geusens pp. Menopause Int. 2007 Sep;13(3):110-5. doi: 10.1258/175404507781605668. Menopause Int. 2007. PMID: 17785036

10

The cost-effectiveness of bisphosphonates in postmenopausal women based on individual long-term fracture risks.

van Staa TP, Kanis JA, Geusens P, Boonen A, Leufkens HG, Cooper C. van Staa TP, et al. Value Health. 2007 Sep-Oct;10(5):348-57. doi: 10.1111/j.1524-4733.2007.00188.x. Value Health. 2007. PMID: 17888099

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results